Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Kura Oncology, Inc. (KURA) had Pre-Tax Income of $-57.20M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$14.11M |
|
$-57.43M |
|
-- |
|
$14.11M |
|
$78.81M |
|
$-64.70M |
|
$7.50M |
|
|
Pre-Tax Income |
$-57.20M |
$-57.20M |
|
$-57.43M |
|
$-57.43M |
|
$-57.43M |
|
$-57.43M |
|
$-64.70M |
|
$-67.12M |
|
87.42M |
|
87.42M |
|
$-0.66 |
|
$-0.66 |
|
| Balance Sheet Financials | |
$724.20M |
|
$2.35M |
|
$19.57M |
|
$743.76M |
|
$89.77M |
|
$7.65M |
|
$289.59M |
|
$379.36M |
|
$364.41M |
|
$364.41M |
|
$364.41M |
|
80.78M |
|
| Cash Flow Statement Financials | |
$-71.93M |
|
$-101.41M |
|
$0.14M |
|
$224.46M |
|
$51.27M |
|
$-173.19M |
|
$7.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.07 |
|
-- |
|
-- |
|
0.02 |
|
0.03 |
|
100.00% |
|
-458.61% |
|
-458.61% |
|
-- |
|
-405.46% |
|
-407.07% |
|
$-72.22M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.29 |
|
310.97 |
|
-15.76% |
|
-15.76% |
|
-7.72% |
|
-15.44% |
|
$4.51 |
|
$-0.83 |
|
$-0.82 |
|